Gene Therapies in Degenerative Retinal Disease Hold
Pending trial results supporting prescribers’ efficacy and safety demands, gene therapies are poised to capture upwards of one-fifth of the AMD, GA and DME...
Source: globenewswire.com
Spherix Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Spherix Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Spherix Network Today - Breaking & Trending Today
EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM
Data from Spherix Global Insights' second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),...
Source: globenewswire.com
Charting New Paths: Non-TNF's Evolving in Rheumatoid
Although crowded, the RA market contains clear pathways for existing players and new entrants to navigate the evolving landscape and expand their market...
Source: globenewswire.com
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen's ... | Region
EXTON, PA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The 2023 announcement of newly approved disease-modifying therapy (DMT) Leqembi (lecanemab) for Alzheimer’s Disease (AD) sparked eager anticipation within both the medical
Source: eagletribune.com
Parkinson's Disease Patient Identification and Education
Earlier screening will be needed in the age of biomarkers....
Source: globenewswire.com